Updates in novel immunotherapeutic strategies for relapsed/refractory AML

Updates in novel immunotherapeutic strategies for relapsed/refractory AML

Acute myeloid leukemia (AML) is a severe hematological malignancy with poor outcomes, particularly in older adults. Traditional treatment options like high-dose chemotherapy often lead to refractory or relapsed AML, with even worse outcomes. New therapies for relapsed and refractory AML are needed,...

Full description

Saved in:
Bibliographic Details
Main Authors: Sawyer Bawek, Sayuri Gurusinghe, Matthew Burwinkel, Amanda Przespolewski
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
acute myeloid leukemia
immunotherapy
relapsed/refractory
cellular therapy
CAR-T
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1374963/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items